FDA Staff Backs Broader Use Of Roche Eye Drug
Swiss pharmaceutical giant Roche Holding AG's blockbuster eye drug Lucentis may become the first approved to treat a diabetes-related vision loss condition, after a U.S. Food and Drug Administration brief released...To view the full article, register now.
Already a subscriber? Click here to view full article